Compass Pathways ADR
Stock
Stock
ISIN: US20451W1018
Ticker: CMPS
US20451W1018
CMPS
Price
Price
CHART BY
Frequently asked questions
What is Compass Pathways ADR's market capitalization?
The market capitalization of Compass Pathways ADR is $185.78M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Compass Pathways ADR?
Compass Pathways ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.301. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Compass Pathways ADR's stock?
Currently, 12 analysts cover Compass Pathways ADR's stock, with a consensus target price of $16.55. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for Compass Pathways ADR?
Compass Pathways ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$178.04M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Compass Pathways ADR?
Compass Pathways ADR has a free cash flow of -$119.24M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Compass Pathways ADR have, and what sector and industry does it belong to?
Compass Pathways ADR employs approximately 166 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Compass Pathways ADR's shares?
The free float of Compass Pathways ADR is 64.17M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $185.78M
- EPS (TTM)
- -$2.301
- Free Float
- 64.17M
- EBITDA (TTM)
- -$178.04M
- Free Cashflow (TTM)
- -$119.24M
Pricing
- 1D span
- $2.56$2.865
- 52W span
- $2.56$9.95
Analyst Ratings
The price target is $16.55 and the stock is covered by 12 analysts.
Buy
12
Hold
0
Sell
0
Information
Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
- Employees
- 166
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US20451W1018
- Primary Ticker
- CMPS
Knockouts
LSX Data · Fundamentals & EOD data from FactSet